NCT00317213View on ClinicalTrials.gov

Smoking Cessation Assistance With LIBERTAL, A Phospholipid Mixture

PHASE2CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

July 31, 2002

Conditions
Smoking
Interventions
DRUG

LIBERTAL- a phospholipid mixture

Trial Locations (1)

Unknown

Arazi Clinic and Modus Clinic, Tel-Aviv and Rehovot

Sponsors
All Listed Sponsors
collaborator

Modus Biological Membranes, Ltd.

INDUSTRY

lead

Kaplan Medical Center

OTHER